Angelman Syndrome As clinical trials

Explore recruiting angelman syndrome as clinical trials.

Recruiting angelman syndrome as studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Angelman Syndrome As trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open-Label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7248824 In Participants with Angelman Syndrome

Netherlands, Italy, Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

A Phase 3, Randomized, Double-blind, Sham-controlled Study Investigating the Efficacy and Safety of GTX-102 in Pediatric Subjects with Angelman Syndrome

Netherlands, Spain, Germany, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Angelman Syndrome As trials by city

Angelman Syndrome As in Toronto Angelman Syndrome As in Vancouver Angelman Syndrome As in Montreal Angelman Syndrome As in Calgary Angelman Syndrome As in Edmonton Angelman Syndrome As in Ottawa Angelman Syndrome As in Winnipeg Angelman Syndrome As in Quebec City Angelman Syndrome As in Hamilton Angelman Syndrome As in Kitchener Angelman Syndrome As in London Angelman Syndrome As in Halifax Angelman Syndrome As in New York Angelman Syndrome As in Los Angeles Angelman Syndrome As in Chicago Angelman Syndrome As in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease